-
It's Time to Enter The Vivint Solar Story, Citi Says In Upgrade
Tuesday, May 7, 2019 - 1:30pm | 457Read More...Full-service residential solar provider Vivint Solar Inc (NYSE: VSLR)'s shares are now investable, according to Citigroup. The Analyst Praful Mehta upgraded Vivint from Neutral to Buy and doubled the price target from $4.25 to $8.50. The Thesis Larger players like Vivint are...
-
NIO's Lower Share Price Charges Interest In Chinese EV Maker
Thursday, April 4, 2019 - 10:50am | 414Read More...The share price of Chinese electric vehicle maker NIO Inc. ADR (NYSE: NIO) has dropped to a level the sell-side likes given expectations for improving sales, leading two analysts to upgrade the stock. The Analysts Bank of America Merrill Lynch analyst Ming-Hsun Lee upgraded Nio from...
-
Citigroup Cuts Mosaic To Neutral, Says Phosphate Supply Outstrips Demand
Friday, March 29, 2019 - 11:41am | 363Read More...With the entry of new competitors, phosphate fundamentals have weakened, according to Citigroup. Moves by Mosaic Co (NYSE: MOS) to improve supply dynamics by curtailing capacity are unlikely to result in a significant upturn, the sell-side firm said in a Friday downgrade. The Analyst...
-
Parliament Rejects May's Brexit Deal Again: What It Means And What's Next
Wednesday, March 13, 2019 - 11:00am | 403Read More...The iShares MSCI United Kingdom Index (NYSE: EWU) and Vanguard FTSE Europe ETF (NYSE: VGK) opened slightly higher Wednesday after U.K. lawmakers voted down another Brexit deal proposed by Prime Minister Theresa May. The proposal failed by 149 votes, representing a shrinking...
-
Gilead Analysts React To Failed NASH Trial: Citigroup, Wells Fargo Downgrade Biotech
Tuesday, February 12, 2019 - 1:12pm | 546Read More...One of the three widely awaited clinical trial readouts from Gilead Sciences, Inc. (NASDAQ: GILD) turned out to be a disappointment, sending its shares down sharply Tuesday. The Analysts Raymond James analyst Steven Seedhouse maintained a Strong Buy rating on Gilead and lowered the...
-
Analysts Focus On Gilead's Late-Stage Data Readouts Following Mixed Q4
Tuesday, February 5, 2019 - 4:26pm | 935Read More...Gilead Sciences, Inc. (NASDAQ: GILD), which focuses on antiviral drugs, reported below-consensus fourth-quarter earnings per share Monday, sending its shares down. The Analysts Raymond James analyst Steven Seedhouse reiterated a Strong Buy rating on the shares of Gilead and trimmed the...
-
Analysts Praise GM's Potential After Investor Day
Monday, January 14, 2019 - 12:22pm | 624Read More...General Motors Company (NYSE: GM) management reinforced bullish theses during its weekend Investor Day, when it previewed 2018 outperformance and guided for 2019 strength. “GM’s unique fundamental position (Pickups + AV + self-help) and the path to our prior $76-134 LT upside potential...
-
After Strong Week, Market Comes Under Pressure From China As Earnings Begin
Monday, January 14, 2019 - 11:04am | 2455Read More...Today’s opening bell rings in the U.S. earnings season, but many investor eyes glanced warily across the Pacific in the early going as markets around the world reeled from more bearish Chinese economic data. There’s a lot to take in as the week gets underway, including earnings from...
-
Citigroup Earnings: Will Consumer Banking Offset Expected Weakness In Institutional Business?
Friday, January 11, 2019 - 1:11pm | 863Read More...Citigroup Inc. (NYSE: C) kicks off earnings season and leads the banks, with its report scheduled for before market open on Monday, Jan. 14. 2018 ended up being a tough year for the stock and C ended 2018 down 30%, with about 19% of that decline in December alone. Shares have bounced back a...
-
Analysts: Altria's Juul Stake A Good Hedge, But Lack Of Control Presents Risks
Friday, December 21, 2018 - 1:14pm | 880Read More...Altria Group Inc (NYSE: MO) announced a $12.8-billion minority stake in Juul Thursday. The stock has fallen since traders began digesting the deal, but many analysts maintain that the investment improves Altria’s positioning in a tough regulatory environment as consumer preferences shift....
-
Merck Is Up 40% In 2018: What's Driving The Rally?
Thursday, November 29, 2018 - 5:11pm | 868Read More...Large-cap pharma stocks have had a decent 2018, with strong earnings momentum primarily responsible for the optimism in the space. Tax cuts enabled companies to augment cash reserves, giving them flexibility to pursue inorganic growth to enrich product pipelines. Here's how large...
-
Analysts Hold The Line On Switch After Q3 Earnings Miss
Wednesday, November 14, 2018 - 2:28pm | 596Read More...Data center operator Switch Inc (NYSE: SWCH) once again disappointed investors with a third-quarter earnings miss Tuesday. The Analysts Credit Suisse analyst Sami Badri reiterated an Outperform rating on Switch with a $14 price target. Citigroup analyst Michael Rollins maintained a...
-
Analysts Say The Market Is Getting Caterpillar Earnings Wrong
Wednesday, October 24, 2018 - 1:51pm | 414Read More...Caterpillar Inc. (NYSE: CAT) dropped another 3 percent Wednesday after the company released its Q3 earnings report Tuesday morning. Wall Street analysts, however, remain bullish on Caterpillar in the near term and see the sell-off as a buying opportunity for investors. Here’s a sampling of...
-
Citi's Chemicals And Agriculture Pair Trade: Buy Mosaic, Hold Sherwin-Williams
Thursday, October 11, 2018 - 10:54am | 483Read More...In a preview of third-quarter earnings in the chemical and agriculture sector, Citigroup highlighted a pair trade in the sector. The sell-side firm recommended buying Mosaic Co (NYSE: MOS) but moving to the sidelines on Sherwin-Williams Co (NYSE: SHW). The Analyst Analyst P.J. Juvekar...
-
Livent's IPO: What You Need To Know
Wednesday, October 10, 2018 - 5:28pm | 480Read More...Lithium company Livent is set to begin trading on the New York Stock Exchange under the ticker symbol “LTHM.” The stock is expected to debut Thursday, Oct. 11, although an official IPO date has not yet been released. The Details The company will sell 20 million shares of common stock at...
















